ID   PC-3M-luc-C6
AC   CVCL_D577
DR   cancercelllines; CVCL_D577
DR   PerkinElmer; 119270
DR   Wikidata; Q54938443
RX   PubMed=14713107;
RX   PubMed=14713108;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Transfected with: UniProtKB; P08659; Firefly luciferase.
CC   Discontinued: PerkinElmer; 119270; true.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9555 ! PC-3M
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
RX   PubMed=14713107; DOI=10.1023/B:CLIN.0000006815.49932.98;
RA   Jenkins D.E., Oei Y.A., Hornig Y.S., Yu S.-F., Dusich J.M., Purchio T.,
RA   Contag P.R.;
RT   "Bioluminescent imaging (BLI) to improve and refine traditional murine
RT   models of tumor growth and metastasis.";
RL   Clin. Exp. Metastasis 20:733-744(2003).
//
RX   PubMed=14713108; DOI=10.1023/B:CLIN.0000006817.25962.87;
RA   Jenkins D.E., Yu S.-F., Hornig Y.S., Purchio T., Contag P.R.;
RT   "In vivo monitoring of tumor relapse and metastasis using
RT   bioluminescent PC-3M-luc-C6 cells in murine models of human prostate
RT   cancer.";
RL   Clin. Exp. Metastasis 20:745-756(2003).
//